BSF Enterprise Plc (BSFAF)
OTCMKTS · Delayed Price · Currency is USD
0.0350
-0.0234 (-40.07%)
At close: May 14, 2025
BSF Enterprise Revenue
BSF Enterprise had revenue of 20.56K GBP in the half year ending March 31, 2025. This brings the company's revenue in the last twelve months to 24.09K, down -64.18% year-over-year. In the fiscal year ending September 30, 2024, BSF Enterprise had annual revenue of 57.82K with 346.77% growth.
Revenue (ttm)
24.09K GBP
Revenue Growth
-64.18%
P/S Ratio
140.78
Revenue / Employee
1.61K GBP
Employees
15
Market Cap
4.38M USD
Revenue Chart
* This company reports financials in GBP.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 57.82K | 44.88K | 346.77% |
Sep 30, 2023 | 12.94K | - | - |
Sep 30, 2022 | - | - | - |
Sep 30, 2021 | - | - | - |
Sep 30, 2020 | - | - | - |
Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Tian'an Technology Group | 2.12M |
Elite Pharmaceuticals | 105.45M |
Glass House Brands | 221.55M |
Northwest Biotherapeutics | 1.09M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.17M |
AMJ Global Technology | 39.00 |
BSF Enterprise News
- 2 years ago - BSF Enterprise PLC Announces Participation in The ThinkEquity Conference - Newsfile Corp
- 2 years ago - BSF Enterprise PLC Provides City-MixTM Bio-Pharmaceutical Update - GlobeNewsWire